Cargando…
Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
BACKGROUND: A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. Patients being treated with oral anticoagulants are at higher risk for bl...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medicina Oral S.L.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303333/ https://www.ncbi.nlm.nih.gov/pubmed/28210451 http://dx.doi.org/10.4317/jced.53219 |